How will hybrid capture-based NGS improve identification of patients with breast cancer who will benefit from trastuzumab therapy?

How will hybrid capture-based NGS improve identification of patients with breast cancer who will benefit from trastuzumab therapy?

How will hybrid capture-based NGS improve identification of patients with breast cancer who will benefit from trastuzumab therapy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Janice Tsang, MBBS, MRCP(UK), FRCP (Lond.)

Specialist in Medical Oncology
Hon. Clinical Assistant Professor
Li Ka Sing Faculty of Medicine
The University of Hong Kong